Mutational profile and haematological response to iron chelation in myelodysplastic syndromes (MDS)

Br J Haematol. 2019 Jun;185(5):954-957. doi: 10.1111/bjh.15655. Epub 2018 Nov 8.
No abstract available

Keywords: MDS; NGS; iron overload; mutation analysis.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Hematology / methods*
  • Humans
  • Iron Chelating Agents / pharmacology
  • Iron Chelating Agents / therapeutic use*
  • Middle Aged
  • Mutation
  • Myelodysplastic Syndromes / drug therapy*

Substances

  • Iron Chelating Agents